You have no items in your shopping cart.
On Promotion
Tested Applications
Reactivity
Conjugation
Unconjugated 203Biotin 32FITC 24HRP 22APC 20PE 20Cy3 15PerCP 9Carrier-free 7Fluoro488 7Fluoro550 7Fluoro594 7Fluoro647 7AP 6APC/Cy5.5 6APC/Cy7 6BF350 6BF405 6BF488 6BF555 6BF594 6BF647 6BF680 6BF700 6BF750 6Cy5 6Cy5.5 6Cy7 6PE/Cy5 6PE/Cy5.5 6PE/Cy7 6Pacific Blue 6PerCP/Cy5.5 6PerCP/Cy7 6RBITC 6IRDye800 5AE 1SureLight 488 1
Biologically Active
Featured Product
Search results for: 'IL-12'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 98.4 KDa. Observed: 125-160 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.1 KDa. Observed: 80-110 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.7&35.8 KDa. Observed: 40&20 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 81.3 KDa. Observed: 80-110 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.9 KDa. Observed: 65-80 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 55.2 KDa. Observed: 60-90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 19.7&35.8 KDa. Observed: 18&40-55 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 34.6 KDa. Observed: 40-47 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.7&36.8 KDa. Observed: 40-55&20 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg- Item 1 of 2
Blocking
Human
Human
Monoclonal
Unconjugated
0.2 mg
![Anti-IL-12/23 [ABT-874 (Briakinumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb2645662_1.png)